PrP is cleaved from the surface of mast cells by ADAM10 and proteases released during degranulation
Journal of Leukocyte Biology · 2024
DOI: 10.1093/jleuko/qiae099 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Leukocyte Biology, 2024. Verfasst von Steven D Willows und 3 weiteren Autor:innen. Beteiligte Einrichtung: Nanotechnology Research Centre, National Research Council Canada, 11421 Saskatchewan Dr, Edmonton, Alberta, T6G 2M9, Canada. Hauptthemen laut MEDLINE: Mast Cells, ADAM10 Protein, Cell Degranulation, Amyloid Precursor Protein Secretases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: National Research Council Canada.
Abstract (Originalsprache)
While several functions of the endogenous prion protein have been studied, the homeostatic function of prion protein is still debated. Notably, prion protein is highly expressed on mast cells, granular immune cells that regulate inflammation. When activated, mast cells shed prion protein, although the mechanism and consequences of this are not yet understood. First, we tested several mast cell lines and found that, while prion protein was almost always present, the total amount differed greatly. Activation of mast cells induced a cleavage of the N-terminal region of prion protein, and this was reduced by protease inhibitors. Exogenous mast cell proteases caused a similar loss of the prion protein N-terminus. Additionally, mast cells shed prion protein in an ADAM10-dependent fashion, even in the absence of activation. Our results suggest that prion protein is cleaved from resting mast cells by ADAM10 and from activated mast cells by mast cell proteases. Prion protein also appears to affect mast cell function, as Prnp−/− bone marrow–derived mast cells showed lower levels of degranulation and cytokine release, as well as lower levels of both FcεRI and CD117. Finally, we sought to provide clinical relevance by measuring the levels of prion protein in bodily fluids of asthmatic patients, a disease that involves the activation of mast cells. We found an N-terminal fragment of prion protein could be detected in human sputum and serum, and the amount of this prion protein fragment was decreased in the serum of patients with asthma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nanotechnology Research Centre, National Research Council Canada, 11421 Saskatchewan Dr, Edmonton, Alberta, T6G 2M9, Canada.
- Department of Medicine, and Alberta Respiratory Centre, University of Alberta, Edmonton, Alberta, 11350 83rd Ave, T6G 2G3, Canada.
- Department of Medicine, and Neurosciences and Mental Health Institute, University of Alberta, Li Ka Shing Centre for Health Research Innovation, Edmonton, Alberta, T6G 2E1, Canada.
- Centre for Prions & Protein Folding Diseases, University of Alberta, 8710 - 112 St NW, Edmonton, Alberta, T6G 2M8, Canada.
- Department of Medical Microbiology and Immunology, University of Alberta, Katz Group Centre, Edmonton, Alberta, T6G 2E1, Canada.
ORCID-Profile: Steven D Willows
Förderung
- National Research Council Canada
Zitieren
APA
Willows, S. D., Vliagoftis, H., Sim, V. L., & Kulka, M. (2024). PrP is cleaved from the surface of mast cells by ADAM10 and proteases released during degranulation. Journal of Leukocyte Biology. https://doi.org/10.1093/jleuko/qiae099
Vancouver
Willows SD, Vliagoftis H, Sim VL, Kulka M. PrP is cleaved from the surface of mast cells by ADAM10 and proteases released during degranulation. Journal of Leukocyte Biology. 2024. doi:10.1093/jleuko/qiae099
BibTeX
@article{Willows2024,
author = {Willows, Steven D and Vliagoftis, Harissios and Sim, Valerie L and Kulka, Marianna},
title = {PrP is cleaved from the surface of mast cells by ADAM10 and proteases released during degranulation},
journal = {Journal of Leukocyte Biology},
year = {2024},
doi = {10.1093/jleuko/qiae099}
}
EUVIMED